The structure and function of the glucagon-like peptide-1 receptor and its ligands

被引:211
|
作者
Donnelly, Dan [1 ]
机构
[1] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England
关键词
GLP-1; GPCR; exendin-4; exenatide; liraglutide; diabetes; glucagon; insulin; VASOACTIVE-INTESTINAL-PEPTIDE; GUINEA-PIG PANCREAS; N-TERMINAL DOMAIN; GLP-1; 7-36; AMIDE; IN-VITRO; INSULIN-SECRETION; DISPERSED ACINI; EXTRACELLULAR DOMAIN; PARATHYROID-HORMONE; BIOLOGICAL-ACTIVITY;
D O I
10.1111/j.1476-5381.2011.01687.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-residue peptide hormone released from intestinal L cells following nutrient consumption. It potentiates the glucose-induced secretion of insulin from pancreatic beta cells, increases insulin expression, inhibits beta-cell apoptosis, promotes beta-cell neogenesis, reduces glucagon secretion, delays gastric emptying, promotes satiety and increases peripheral glucose disposal. These multiple effects have generated a great deal of interest in the discovery of long-lasting agonists of the GLP-1 receptor (GLP-1R) in order to treat type 2 diabetes. This review article summarizes the literature regarding the discovery of GLP-1 and its physiological functions. The structure, function and sequenceactivity relationships of the hormone and its natural analogue exendin-4 (Ex4) are reviewed in detail. The current knowledge of the structure of GLP-1R, a Family B GPCR, is summarized and discussed, before its known interactions with the principle peptide ligands are described and summarized. Finally, progress in discovering non-peptide ligands of GLP-1R is reviewed. GLP-1 is clearly an important hormone linking nutrient consumption with blood sugar control, and therefore knowledge of its structure, function and mechanism of action is of great importance.
引用
收藏
页码:27 / 41
页数:15
相关论文
共 50 条
  • [41] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [42] Glucagon-like peptide-1 agonists
    Padwal, Raj
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [43] NEPHROPROTECTIVE POTENTIAL OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
    Shamhalova, Minara S.
    Sklyanik, Igor A.
    Shestakova, Marina V.
    DIABETES MELLITUS, 2020, 23 (01): : 56 - 64
  • [44] Signal transduction and desensitization of the glucagon-like peptide-1 receptor
    Thorens, B
    Widmann, C
    ACTA PHYSIOLOGICA SCANDINAVICA, 1996, 157 (03): : 317 - 319
  • [45] Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists
    Chen, J.
    Cooper, M. E.
    Coughlan, M. T.
    DIABETES & METABOLISM, 2025, 51 (03)
  • [46] Perioperative Implications of Glucagon-like Peptide-1 Receptor Agonists
    Wolfe, Rachel C.
    JOURNAL OF PERIANESTHESIA NURSING, 2024, 39 (06) : 1108 - 1110
  • [47] Glucagon-like peptide-1 receptor expression in the human eye
    Hebsgaard, Josephine B.
    Pyke, Charles
    Yildirim, Emre
    Knudsen, Lotte B.
    Heegaard, Steffen
    Kvist, Peter H.
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2304 - 2308
  • [48] Charaterization of binding determinants of glucagon-like peptide-1 receptor
    Xiao, Q
    Jeng, W
    Wheeler, MB
    DIABETES, 2000, 49 : A228 - A228
  • [49] Expression of the Glucagon-Like Peptide-1 Receptor in Psoriasis Plaques
    Faurschou, Annesofie
    Pedersen, Jens
    Gyldenlove, Mette
    Poulsen, Sten S.
    Holst, Jens J.
    Zachariae, Claus
    Skov, Lone
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES, 2012, 61 : A704 - A705
  • [50] Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity
    Jensterle, Mojca
    Janez, Andrej
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06): : 599 - 608